Procedural characteristics and cardiovascular outcomes in patients undergoing drug-coated balloon angioplasty for de novo lesions in large coronary arteries: an observational study
Heart and Vessels · 2024
DOI: 10.1007/s00380-024-02368-8 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Heart and Vessels, 2024. Verfasst von Hiroshi Ueda und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, Koseikai Takai Hospital, 470-8, Kuranosho-Cho, Tenri-City, 6320006, Japan. h-ueda@takai-hp.com. Hauptthemen laut MEDLINE: Angioplasty, Balloon, Coronary, Coronary Angiography, Coronary Vessels, Coronary Artery Disease. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 15 Literaturangaben.
Abstract (Originalsprache)
Limited data exist regarding drug-coated balloon (DCB) treatment in de novo large coronary arteries. We sought to demonstrate procedural characteristics, residual stenosis, and clinical outcomes following DCB angioplasty for de novo lesions in large versus small coronary arteries. The study included 184 consecutive patients with 223 de novo coronary lesions undergoing paclitaxel DCB angioplasty between January 2019 and August 2020, who were divided according to whether the DCB diameter was ≥ 3.0 mm (large group, n = 58) or < 3.0 mm (small group, n = 125). The large group had a higher proportion of acute coronary syndrome more commonly with ostial, bifurcation, and calcified lesions in large vessels and received lesion preparation with more frequent use of scoring or cutting balloons and atherectomy devices compared to the small group. Postprocedural angiographic diameter stenosis was smaller in the large group compared to the small group (31% [22-37] vs. 35% [26-42], p = 0.032), and intravascular ultrasound revealed no significant difference in postprocedural area stenosis between the groups (66.2 ± 7.7% vs. 67.9 ± 7.8%; p = 0.26). The median follow-up duration was 995 days. The incidence of a composite of all-cause death, myocardial infarction, stroke, or target lesion revascularization was similar between the groups (log-rank p = 0.41) and was influenced by the presence of acute coronary syndrome and anemia but not by DCB diameter. The rate of cardiovascular outcomes after DCB treatment was comparable in de novo large and small coronary arteries. Notably, well-planned lesion preparation with intravascular imaging guidance was prevalent in large vessels.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiovascular Medicine, Koseikai Takai Hospital, 470-8, Kuranosho-Cho, Tenri-City, 6320006, Japan. h-ueda@takai-hp.com.
- Department of Cardiovascular Medicine, Koseikai Takai Hospital, 470-8, Kuranosho-Cho, Tenri-City, 6320006, Japan.
Zitieren
APA
Ueda, H., Fujiwara, Y., Nishida, Y., Maenaka, M., Yoshimura, K., Oshida, Y., Matsuhisa, S., Yoshida, N., Yoshitani, H., Kuga, Y., Ueda, K., & Nishida, Y. (2024). Procedural characteristics and cardiovascular outcomes in patients undergoing drug-coated balloon angioplasty for de novo lesions in large coronary arteries: an observational study. Heart and Vessels. https://doi.org/10.1007/s00380-024-02368-8
Vancouver
Ueda H, Fujiwara Y, Nishida Y, Maenaka M, Yoshimura K, Oshida Y, et al. Procedural characteristics and cardiovascular outcomes in patients undergoing drug-coated balloon angioplasty for de novo lesions in large coronary arteries: an observational study. Heart and Vessels. 2024. doi:10.1007/s00380-024-02368-8
BibTeX
@article{Ueda2024,
author = {Ueda, Hiroshi and Fujiwara, Yoshihiro and Nishida, Yusuke and Maenaka, Motoyoshi and Yoshimura, Kojiro and Oshida, Yuki and Matsuhisa, Seiji and Yoshida, Naohiro and Yoshitani, Hidetoshi and Kuga, Yukiko and Ueda, Kazuya and Nishida, Yasunori},
title = {Procedural characteristics and cardiovascular outcomes in patients undergoing drug-coated balloon angioplasty for de novo lesions in large coronary arteries: an observational study},
journal = {Heart and Vessels},
year = {2024},
doi = {10.1007/s00380-024-02368-8}
}
EUVIMED